Copyright Reports & Markets. All rights reserved.

Global Activin Receptor Type 1 Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Activin Receptor Type 1 Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Activin Receptor Type 1 Market Size Growth Rate by Product
      • 1.4.2 LJPC-6417
      • 1.4.3 TP-0184
      • 1.4.4 Dipyridamole
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Activin Receptor Type 1 Market Size Growth Rate by End User
      • 1.5.2 Alport Syndrome
      • 1.5.3 Chronic Kidney Disease
      • 1.5.4 Kidney Fibrosis
      • 1.5.5 Obesity
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Activin Receptor Type 1 Market Size
      • 2.1.1 Global Activin Receptor Type 1 Revenue 2014-2025
      • 2.1.2 Global Activin Receptor Type 1 Sales 2014-2025
    • 2.2 Activin Receptor Type 1 Growth Rate by Regions
      • 2.2.1 Global Activin Receptor Type 1 Sales by Regions
      • 2.2.2 Global Activin Receptor Type 1 Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Activin Receptor Type 1 Sales by Manufacturers
      • 3.1.1 Activin Receptor Type 1 Sales by Manufacturers
      • 3.1.2 Activin Receptor Type 1 Sales Market Share by Manufacturers
      • 3.1.3 Global Activin Receptor Type 1 Market Concentration Ratio (CR5 and HHI)
    • 3.2 Activin Receptor Type 1 Revenue by Manufacturers
      • 3.2.1 Activin Receptor Type 1 Revenue by Manufacturers (2014-2019)
      • 3.2.2 Activin Receptor Type 1 Revenue Share by Manufacturers (2014-2019)
    • 3.3 Activin Receptor Type 1 Price by Manufacturers
    • 3.4 Activin Receptor Type 1 Manufacturing Base Distribution, Product Types
      • 3.4.1 Activin Receptor Type 1 Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Activin Receptor Type 1 Product Type
      • 3.4.3 Date of International Manufacturers Enter into Activin Receptor Type 1 Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Activin Receptor Type 1 Sales by Product
    • 4.2 Global Activin Receptor Type 1 Revenue by Product
    • 4.3 Activin Receptor Type 1 Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Activin Receptor Type 1 Breakdown Data by End User

    6 North America

    • 6.1 North America Activin Receptor Type 1 by Countries
      • 6.1.1 North America Activin Receptor Type 1 Sales by Countries
      • 6.1.2 North America Activin Receptor Type 1 Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Activin Receptor Type 1 by Product
    • 6.3 North America Activin Receptor Type 1 by End User

    7 Europe

    • 7.1 Europe Activin Receptor Type 1 by Countries
      • 7.1.1 Europe Activin Receptor Type 1 Sales by Countries
      • 7.1.2 Europe Activin Receptor Type 1 Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Activin Receptor Type 1 by Product
    • 7.3 Europe Activin Receptor Type 1 by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Activin Receptor Type 1 by Countries
      • 8.1.1 Asia Pacific Activin Receptor Type 1 Sales by Countries
      • 8.1.2 Asia Pacific Activin Receptor Type 1 Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Activin Receptor Type 1 by Product
    • 8.3 Asia Pacific Activin Receptor Type 1 by End User

    9 Central & South America

    • 9.1 Central & South America Activin Receptor Type 1 by Countries
      • 9.1.1 Central & South America Activin Receptor Type 1 Sales by Countries
      • 9.1.2 Central & South America Activin Receptor Type 1 Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Activin Receptor Type 1 by Product
    • 9.3 Central & South America Activin Receptor Type 1 by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Activin Receptor Type 1 by Countries
      • 10.1.1 Middle East and Africa Activin Receptor Type 1 Sales by Countries
      • 10.1.2 Middle East and Africa Activin Receptor Type 1 Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Activin Receptor Type 1 by Product
    • 10.3 Middle East and Africa Activin Receptor Type 1 by End User

    11 Company Profiles

    • 11.1 Blueprint Medicines Corp
      • 11.1.1 Blueprint Medicines Corp Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Blueprint Medicines Corp Activin Receptor Type 1 Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Blueprint Medicines Corp Activin Receptor Type 1 Products Offered
      • 11.1.5 Blueprint Medicines Corp Recent Development
    • 11.2 Daiichi Sankyo Company Ltd
      • 11.2.1 Daiichi Sankyo Company Ltd Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Products Offered
      • 11.2.5 Daiichi Sankyo Company Ltd Recent Development
    • 11.3 La Jolla Pharmaceutical Company
      • 11.3.1 La Jolla Pharmaceutical Company Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 La Jolla Pharmaceutical Company Activin Receptor Type 1 Products Offered
      • 11.3.5 La Jolla Pharmaceutical Company Recent Development
    • 11.4 Oncodesign SA
      • 11.4.1 Oncodesign SA Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Oncodesign SA Activin Receptor Type 1 Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Oncodesign SA Activin Receptor Type 1 Products Offered
      • 11.4.5 Oncodesign SA Recent Development
    • 11.5 Tolero Pharmaceuticals Inc
      • 11.5.1 Tolero Pharmaceuticals Inc Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Products Offered
      • 11.5.5 Tolero Pharmaceuticals Inc Recent Development

    12 Future Forecast

    • 12.1 Activin Receptor Type 1 Market Forecast by Regions
      • 12.1.1 Global Activin Receptor Type 1 Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Activin Receptor Type 1 Revenue Forecast by Regions 2019-2025
    • 12.2 Activin Receptor Type 1 Market Forecast by Product
      • 12.2.1 Global Activin Receptor Type 1 Sales Forecast by Product 2019-2025
      • 12.2.2 Global Activin Receptor Type 1 Revenue Forecast by Product 2019-2025
    • 12.3 Activin Receptor Type 1 Market Forecast by End User
    • 12.4 North America Activin Receptor Type 1 Forecast
    • 12.5 Europe Activin Receptor Type 1 Forecast
    • 12.6 Asia Pacific Activin Receptor Type 1 Forecast
    • 12.7 Central & South America Activin Receptor Type 1 Forecast
    • 12.8 Middle East and Africa Activin Receptor Type 1 Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Activin Receptor Type 1 Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Activin Receptor Type 1 market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Activin Receptor Type 1 market based on company, product type, end user and key regions.

      This report studies the global market size of Activin Receptor Type 1 in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Activin Receptor Type 1 in these regions.
      This research report categorizes the global Activin Receptor Type 1 market by top players/brands, region, type and end user. This report also studies the global Activin Receptor Type 1 market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Blueprint Medicines Corp
      Daiichi Sankyo Company Ltd
      La Jolla Pharmaceutical Company
      Oncodesign SA
      Tolero Pharmaceuticals Inc

      Market size by Product
      LJPC-6417
      TP-0184
      Dipyridamole
      Others
      Market size by End User
      Alport Syndrome
      Chronic Kidney Disease
      Kidney Fibrosis
      Obesity
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Activin Receptor Type 1 market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Activin Receptor Type 1 market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Activin Receptor Type 1 companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Activin Receptor Type 1 submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Activin Receptor Type 1 are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Activin Receptor Type 1 market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now